Precision’s Abhishek Sharma Selected for World Heart Federation’s Emerging Leaders Program
Congratulations to Associate Health Economist Abhishek Sharma, part of Precision Health Economics’s Evidence Strategy, Generation, and Communications team, for his acceptance into the World Heart Federation’s Emerging Leaders (EL) program. The program is part of a WHF initiative to reduce premature mortality from noncommunicable, chronic diseases by 25% by 2025.
Created in 2014 to recognize leaders in cardiovascular research, the EL program seeks to build capacity, professional development, mentorship, and networking around the globe. Each year, through a competitive process, 25 ELs are selected. They take part in online training, covering essential topics in the field of implementation science, health systems, and health policy research. The ELs also meet face-to-face for a 5-day think tank seminar with senior CVD investigators, collaborating on multinational innovative and interdisciplinary projects aimed at reducing CVD premature mortality.
Abhishek will be participating in this year’s think tank focusing on access to essential medicines in Cape Town, South Africa, June 18-23.
By: Jason Shafrin, PhD Sr. Director, Policy and Economics and Jacki Chou, MPL Senior Director, Policy and Economics The recent announcement that CVS Caremark will use value-based metrics to inform formulary design at first appears a step in the right direction. However, using value measurements from a single nongovernmental organization—the Institute for Clinical and Economic Review (ICER)—based on a limited picture of treatment value may be problematic. Using this single assessment of value in an effort solely to exclude drugs from a major insurance formulary is even more worrisome and fails to recognize the heterogeneity in patient clinical needs and preferences.